Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP811548.RAwgM-AtOc55vRCN-tmH1kN__mQGbdFMVd19rO__8Ibz4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP811548.RAwgM-AtOc55vRCN-tmH1kN__mQGbdFMVd19rO__8Ibz4130_assertion type Assertion NP811548.RAwgM-AtOc55vRCN-tmH1kN__mQGbdFMVd19rO__8Ibz4130_head.
- NP811548.RAwgM-AtOc55vRCN-tmH1kN__mQGbdFMVd19rO__8Ibz4130_assertion description "[In this study, a decrease in matrix metalloprotease-9 (MMP-9) but not of MMP-2 and the tissue inhibitors of MMP (TIMP-1 and TMP-2) was observed in the plasma of chronic hepatitis C patients at the end of the follow-up period after ribavirin plus interferon-alpha2b (PEG-IFN-alpha2b) treatment in sustained virologic responders but not in nonresponders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP811548.RAwgM-AtOc55vRCN-tmH1kN__mQGbdFMVd19rO__8Ibz4130_provenance.
- NP811548.RAwgM-AtOc55vRCN-tmH1kN__mQGbdFMVd19rO__8Ibz4130_assertion evidence source_evidence_literature NP811548.RAwgM-AtOc55vRCN-tmH1kN__mQGbdFMVd19rO__8Ibz4130_provenance.
- NP811548.RAwgM-AtOc55vRCN-tmH1kN__mQGbdFMVd19rO__8Ibz4130_assertion SIO_000772 16108728 NP811548.RAwgM-AtOc55vRCN-tmH1kN__mQGbdFMVd19rO__8Ibz4130_provenance.
- NP811548.RAwgM-AtOc55vRCN-tmH1kN__mQGbdFMVd19rO__8Ibz4130_assertion wasDerivedFrom befree-20140225 NP811548.RAwgM-AtOc55vRCN-tmH1kN__mQGbdFMVd19rO__8Ibz4130_provenance.
- NP811548.RAwgM-AtOc55vRCN-tmH1kN__mQGbdFMVd19rO__8Ibz4130_assertion wasGeneratedBy ECO_0000203 NP811548.RAwgM-AtOc55vRCN-tmH1kN__mQGbdFMVd19rO__8Ibz4130_provenance.